TABLE OF CONTENTS
1 INTRODUCTION 39
1.1 OBJECTIVES OF THE STUDY 39
1.2 MARKET DEFINITION 39
1.3 OVERVIEW OF THE GLOBAL FLOW CYTOMETRY MARKET 39
1.4 LIMITATIONS 41
1.5 MARKETS COVERED 41
2 MARKET SEGMENTATION 44
2.1 MARKETS COVERED 44
2.2 GEOGRAPHICAL SCOPE 45
2.3 YEARS CONSIDERED FOR THE STUDY 46
2.4 CURRENCY AND PRICING 46
2.5 DBMR TRIPOD DATA VALIDATION MODEL 47
2.6 MULTIVARIATE MODELLING 50
2.7 PRODUCT SEGMENT LIFELINE CURVE 50
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
2.9 DBMR MARKET POSITION GRID 52
2.10 MARKET APPLICATION COVERAGE GRID 53
2.11 VENDOR SHARE ANALYSIS 54
2.12 SECONDARY SOURCES 55
2.13 ASSUMPTIONS 55
3 EXECUTIVE SUMMARY 56
4 PREMIUM INSIGHTS 60
4.1 PORTERS FIVE FORCES 62
4.2 PESTEL ANALYSIS 63
5 MARKET OVERVIEW 64
5.1 DRIVERS 66
5.1.1 RISING PREVALENCE OF CHRONIC DISEASES 66
5.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS 67
5.1.3 INCREASE IN USE OF FLOW CYTOMETRY IN DRUG DISCOVERY 68
5.1.4 GROWTH IN STEM CELL RESEARCH AND ACQUISITION OF RECOMBINATION OF DNA TECHNOLOGIES 70
5.2 RESTRAINTS 71
5.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS 71
5.2.2 LIMITATIONS OF FLOW CYTOMETRY 72
5.2.3 LACK OF SKILLED PROFESSIONALS 73
5.3 OPPORTUNITIES 74
5.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA 74
5.3.2 DEVELOPMENT IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES 75
5.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 76
5.3.4 DEVELOPING A PIPELINE OF STEM CELL RESEARCH 77
5.4 CHALLENGES 77
5.4.1 DIFFICULTY IN THE DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS 77
5.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT 78
6 GLOBAL FLOW CYTOMETRY MARKET, BY PRODUCT 80
6.1 OVERVIEW 81
6.2 REAGENTS AND CONSUMABLES 84
6.2.1 DYE 85
6.2.2 ANTIBODIES 85
6.2.3 BEADS 85
6.2.4 OTHERS 85
6.3 FLOW CYTOMETRY INSTRUMENTS 85
6.3.1 CELL ANALYZERS 86
6.3.1.1 CELL ANALYZERS, BY TYPE 87
6.3.1.1.1 IMAGING FLOW CYTOMETERS 87
6.3.1.1.2 NON-IMAGING FLOW CYTOMETERS 87
6.3.1.2 CELL ANALYZERS, BY MODALITY 87
6.3.1.2.1 BENCHTOP 87
6.3.1.2.2 STANDALONE 87
6.3.2 CELL SORTERS 88
6.3.2.1 BENCHTOP 88
6.3.2.2 STANDALONE 88
6.4 ACCESSORIES 88
6.4.1 FILTERS 89
6.4.2 DETECTORS 89
6.4.3 OTHERS 89
6.5 SERVICES 90
6.6 SOFTWARE 90
7 GLOBAL FLOW CYTOMETRY MARKET, BY TECHNOLOGY 92
7.1 OVERVIEW 93
7.2 CELL-BASED FLOW CYTOMETRY 97
7.3 BEAD-BASED FLOW CYTOMETRY 98
8 GLOBAL FLOW CYTOMETRY MARKET, BY APPLICATION 99
8.1 OVERVIEW 100
8.2 RESEARCH APPLICATIONS 104
8.2.1 CELL CYCLE ANALYSIS 105
8.2.2 CELL SORTING/SCREENING 105
8.2.3 CELL TRANSFECTION/VIABILITY 105
8.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY 106
8.2.4.1 DRUG DISCOVERY 106
8.2.4.2 STEM CELL RESEARCH 106
8.2.4.3 IN VITRO TOXICITY TESTING 106
8.2.5 IMMUNOLOGY 106
8.2.6 APOPTOSIS 106
8.2.7 CELL COUNTING 106
8.2.8 OTHERS 106
8.3 CLINICAL APPLICATIONS 107
8.3.1 HAEMATOLOGY 108
8.3.2 CANCER 108
8.3.3 IMMUNODEFICIENCY DISEASES 108
8.3.4 ORGAN TRANSPLANTATION 108
8.3.5 OTHER CLINICAL APPLICATION 108
8.4 INDUSTRIAL APPLICATIONS 108
9 GLOBAL FLOW CYTOMETRY MARKET, BY END USER 110
9.1 OVERVIEW 111
9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES 114
9.3 ACADEMIC & RESEARCH INSTITUTES 115
9.4 HOSPITALS 116
9.5 CLINICAL TESTING LABORATORIES 117
9.6 BLOOD BANK 118
9.7 OTHERS 119
10 GLOBAL FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL 120
10.1 OVERVIEW 121
10.2 RETAIL SALES 124
10.3 DIRECT TENDERS 125
11 GLOBAL FLOW CYTOMETRY MARKET, BY GEOGRAPHY 126
11.1 OVERVIEW 127
11.2 NORTH AMERICA 132
11.2.1 U.S. 141
11.2.2 CANADA 145
11.2.3 MEXICO 149
11.3 EUROPE 153
11.3.1 GERMANY 161
11.3.2 FRANCE 165
11.3.3 U.K. 169
11.3.4 ITALY 173
11.3.5 SPAIN 177
11.3.6 RUSSIA 181
11.3.7 NETHERLANDS 185
11.3.8 SWITZERLAND 189
11.3.9 TURKEY 193
11.3.10 BELGIUM 197
11.3.11 REST OF EUROPE 201
11.4 ASIA-PACIFIC 202
11.4.1 JAPAN 210
11.4.2 CHINA 214
11.4.3 INDIA 218
11.4.4 SOUTH KOREA 222
11.4.5 AUSTRALIA 226
11.4.6 SINGAPORE 230
11.4.7 THAILAND 234
11.4.8 MALAYSIA 238
11.4.9 INDONESIA 242
11.4.10 PHILIPPINES 246
11.4.11 REST OF ASIA-PACIFIC 250
11.5 SOUTH AMERICA 251
11.5.1 BRAZIL 259
11.5.2 ARGENTINA 263
11.5.3 REST OF SOUTH AMERICA 267
11.6 MIDDLE EAST AND AFRICA 268
11.6.1 SOUTH AFRICA 276
11.6.2 SAUDI ARABIA 280
11.6.3 U.A.E 284
11.6.4 EGYPT 288
11.6.5 REST OF MIDDLE EAST AND ARICA 292
12 GLOBAL FLOW CYTOMETRY MARKET, COMPANY LANDSCAPE 293
12.1 COMPANY SHARE ANALYSIS: GLOBAL 293
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 294
12.3 COMPANY SHARE ANALYSIS: EUROPE 295
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 296
13 SWOT ANALYSIS 297
14 COMPANY PROFILE 298
14.1 THERMO FISHER SCIENTIFIC INC. 298
14.1.1 COMPANY SNAPSHOT 298
14.1.2 REVENUE ANALYSIS 299
14.1.3 COMPANY SHARE ANALYSIS 299
14.1.4 PRODUCT PORTFOLIO 300
14.1.5 RECENT DEVELOPMENTS 300
14.2 BD 302
14.2.1 COMPANY SNAPSHOT 302
14.2.2 REVENUE ANALYSIS 302
14.2.3 COMPANY SHARE ANALYSIS 303
14.2.4 PRODUCT PORTFOLIO 303
14.2.5 RECENT DEVELOPMENT 304
14.2.5.1 COLLABORATION 304
14.3 AGILENT TECHNOLOGIES, INC. 305
14.3.1 COMPANY SNAPSHOT 305
14.3.2 REVENUE ANALYSIS 305
14.3.3 COMPANY SHARE ANALYSIS 306
14.3.4 PRODUCT PORTFOLIO 306
14.3.5 RECENT DEVELOPMENTS 307
14.4 SARTORIUS AG 308
14.4.1 COMPANY SNAPSHOT 308
14.4.2 REVENUE ANALYSIS 308
14.4.3 COMPANY SHARE ANALYSIS 309
14.4.4 PRODUCT PORTFOLIO 309
14.4.5 RECENT DEVELOPMENT 310
14.5 NEXCELOM BIOSCIENCE LLC 311
14.5.1 COMPANY SNAPSHOT 311
14.5.2 PRODUCT PORTFOLIO 311
14.5.3 RECENT DEVELOPMENT 311
14.5.4 COMPANY SHARE ANALYSIS 312
14.6 APOGEE FLOW SYSTEMS LTD. 313
14.6.1 COMPANY SNAPSHOT 313
14.6.2 PRODUCT PORTFOLIO 313
14.6.3 RECENT DEVELOPMENT 313
14.7 BAY BIOSCIENCE CO., LTD. 314
14.7.1 COMPANY SNAPSHOT 314
14.7.2 PRODUCT PORTFOLIO 314
14.7.3 RECENT DEVELOPMENT 314
14.8 BIOMRIEUX 315
14.8.1 COMPANY SNAPSHOT 315
14.8.2 REVENUE ANALYSIS 316
14.8.3 PRODUCT PORTFOLIO 316
14.8.4 RECENT DEVELOPMENT 316
14.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION) 317
14.9.1 COMPANY SNAPSHOT 317
14.9.2 REVENUE ANALYSIS 317
14.9.3 PRODUCT PORTFOLIO 318
14.9.4 RECENT DEVELOPMENTS 319
14.9.4.1 ACQUISITION 319
14.9.4.2 PRODUCT LAUNCH 319
14.10 BENNUBIO INC. 321
14.10.1 COMPANY SNAPSHOT 321
14.10.2 PRODUCT PORTFOLIO 321
14.10.3 RECENT DEVELOPMENT 321
14.11 BIOLEGEND, INC. 322
14.11.1 COMPANY SNAPSHOT 322
14.11.2 PRODUCT PORTFOLIO 322
14.11.3 RECENT DEVELOPMENT 324
14.12 BIO-RAD LABORATORIES, INC. 325
14.12.1 COMPANY SNAPSHOT 325
14.12.2 REVENUE ANALYSIS 325
14.12.3 PRODUCT PORTFOLIO 326
14.12.4 RECENT DEVELOPMENT 326
14.13 CELL SIGNALING TECHNOLOGY, INC. 327
14.13.1 COMPANY SNAPSHOT 327
14.13.2 PRODUCT PORTFOLIO 327
14.13.3 RECENT DEVELOPMENT 328
14.14 CELLKRAFT BIOTECH PVT. LTD 329
14.14.1 COMPANY SNAPSHOT 329
14.14.2 PRODUCT PORTFOLIO 329
14.14.3 RECENT DEVELOPMENT 330
14.15 CYTEK BIOSCIENCES 331
14.15.1 COMPANY SNAPSHOT 331
14.15.2 PRODUCT PORTFOLIO 331
14.15.3 RECENT DEVELOPMENTS 332
14.15.3.1 PRODUCT LAUNCH 332
14.15.3.2 ACQUISITION 333
14.16 CYTOBUOY B.V. 334
14.16.1 COMPANY SNAPSHOT 334
14.16.2 PRODUCT PORTFOLIO 334
14.16.3 RECENT DEVELOPMENT 334
14.17 CYTONOME/ST, LLC 335
14.17.1 COMPANY SNAPSHOT 335
14.17.2 PRODUCT PORTFOLIO 335
14.18 COHERENT CORP. 336
14.18.1 COMPANY SNAPSHOT 336
14.18.2 REVENUE ANALYSIS 336
14.18.3 PRODUCT PORTFOLIO 337
14.18.4 RECENT DEVELOPMENTS 337
14.18.4.1 ANNOUNCEMENT 337
14.18.4.2 PRODUCT LAUNCH 337
14.18.4.3 AWARDS 338
14.18.5 RECENT DEVELOPMENT 338
14.19 ELABSCIENCE BIOTECHNOLOGY INC. 339
14.19.1 COMPANY SNAPSHOT 339
14.19.2 PRODUCT PORTFOLIO 339
14.19.3 RECENT DEVELOPMENT 340
14.20 ENZO BIOCHEM INC. 341
14.20.1 COMPANY SNAPSHOT 341
14.20.2 REVENUE ANALYSIS 342
14.20.3 PRODUCT PORTFOLIO 342
14.20.4 RECENT DEVELOPMENT 342

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.